Respiratory virus modulation of host nucleocytoplasmic transport; Target for therapeutic intervention?

Frontiers in Microbiology

Volumn 6, Issue AUG, 2015, Pages

  Caly, Leon ^a   Ghildyal, Reena ^b   Jans, David A ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

Author keywords

Anti viral strategies; Exportins; Importins; Influenza; Nuclear transport; Respiratory syncytial viruses; Rhinovirus

Indexed keywords

ALPHA INTERFERON RECEPTOR; AMANTADINE DERIVATIVE; BETA INTERFERON; CADHERIN; EXPORTIN 1; GLYCOPROTEIN; GRANZYME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSINE PHOSPHATE; INTERFERON REGULATORY FACTOR 3; LEPTOMYCIN B; MOTAVIZUMAB; NUCLEAR FACTOR; PALIVIZUMAB; PROTEIN SAM68; PROTEINASE; RIBAVIRIN; RUPINTRIVIR; SINGLE STRANDED RNA; TRANSCRIPTION FACTOR DAF 16; VERDINEXOR; VIRUS FUSION PROTEIN; ZINC FINGER PROTEIN;

APOPTOSIS; CELL CYCLE ARREST; CELL NUCLEUS TRANSPLANTATION; ENDOCYTOSIS; HOST CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RHINOVIRUS; IMMUNE RESPONSE; INFLUENZA; INNATE IMMUNITY; MODULATION; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PINOCYTOSIS; RESPIRATORY VIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRION; VIRUS ATTACHMENT; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 84941001917     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00848     Document Type: Review

References (125)

1. Alvisi, G., Musiani, D., Jans, D. A., and Ripalti, A. (2007). An importin alpha/beta-recognized bipartite nuclear localization signal mediates targeting of the human herpes simplex virus type 1 DNA polymerase catalytic subunit pUL30 to the nucleus. Biochemistry 46, 9155-9163. doi: 10.1021/bi7002394
2. American Academy of Pediatrics Committee on Infectious and American Academy of Pediatrics Bronchiolitis Guidelines. (2014). Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134, 415-420. doi: 10.1542/peds.2014-1665
3. Amineva, S. P., Aminev, A. G., Palmenberg, A. C., and Gern, J. E. (2004). Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells. J. Gen. Virol. 85(Pt 10), 2969-2979. doi: 10.1099/vir.0.80164-0
4. Bawage, S. S., Tiwari, P. M., Pillai, S., Dennis, V., and Singh, S. R. (2013). Recent advances in diagnosis, prevention and treatment of human respiratory syncytial virus. Adv. Virol. 2013:595768. doi: 10.1155/2013/595768
5. Bednenko, J., Cingolani, G., and Gerace, L. (2003). Importin beta contains a COOH-terminal nucleoporin binding region important for nuclear transport. J. Cell Biol. 162, 391-401. doi: 10.1083/jcb.200303085
6. Binford, S. L., Weady, P. T., Maldonado, F., Brothers, M. A., Matthews, D. A., and Patick, A. K. (2007). In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 51, 4366-4373. doi: 10.1128/AAC.00905-07
7. Blomqvist, S., Savolainen, C., Raman, L., Roivainen, M., and Hovi, T. (2002). Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J. Clin. Microbiol. 40, 4218-4223. doi: 10.1128/JCM.40.11.4218-4223.2002
8. Bochkov, Y. A., Watters, K., Ashraf, S., Griggs, T. F., Devries, M. K., Jackson, D. J., et al. (2015). Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl. Acad. Sci. U.S.A. 112, 5485-5490. doi: 10.1073/pnas.1421178112
9. Boivin, S., and Hart, D. J. (2011). Interaction of the influenza A virus polymerase PB2 C-terminal region with importin alpha isoforms provides insights into host adaptation and polymerase assembly. J. Biol. Chem. 286, 10439-10448. doi: 10.1074/jbc.M110.182964
10. Brunotte, L., Flies, J., Bolte, H., Reuther, P., Vreede, F., and Schwemmle, M. (2014). The nuclear export protein of H5N1 influenza A viruses recruits Matrix 1 (M1) protein to the viral ribonucleoprotein to mediate nuclear export. J. Biol. Chem. 289, 20067-20077. doi: 10.1074/jbc.M114.569178
11. Cao, S., Liu, X., Yu, M., Li, J., Jia, X., Bi, Y., et al. (2012). A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication. J. Virol. 86, 4883-4891. doi: 10.1128/JVI.06586-11
12. Centers for Disease Control and Prevention. (2010). The 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010. Available at: http://www.cdc.gov/h1n1flu/cdcresponse.htm [accessed June 16, 2010].
13. Chavez-Bueno, S., Mejias, A., Merryman, R. A., Ahmad, N., Jafri, H. S., and Ramilo, O. (2007). Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatric Infect. Dis. J. 26, 1089-1093. doi: 10.1097/INF.0b013e3181343b7e
14. Conti, E., Uy, M., Leighton, L., Blobel, G., and Kuriyan, J. (1998). Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin alpha. Cell 94, 193-204. doi: 10.1016/S0092-8674(00)81419-1
15. Cordingley, M. G., Callahan, P. L., Sardana, V. V., Garsky, V. M., and Colonno, R. J. (1990). Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. J. Biol. Chem. 265, 9062-9065.
16. Costa, L. D., Costa, P. S., and Camargos, P. A. (2014). Exacerbation of asthma and airway infection: is the virus the villain? J. Pediatr. (Rio J.) 90, 542-555. doi: 10.1016/j.jped.2014.07.001
17. Cros, J. F., Garcia-Sastre, A., and Palese, P. (2005). An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic 6, 205-213. doi: 10.1111/j.1600-0854.2005.00263.x
18. Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., et al. (1964). Antiviral activity of 1-adamantanamine (amantadine). Science 144, 862-863. doi: 10.1126/science.144.3620.862
19. Deng, T., Engelhardt, O. G., Thomas, B., Akoulitchev, A. V., Brownlee, G. G., and Fodor, E. (2006). Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J. Virol. 80, 11911-11919. doi: 10.1128/JVI.01565-06
20. De Palma, A. M., Vliegen, I., De Clercq, E., and Neyts, J. (2008). Selective inhibitors of picornavirus replication. Med. Res. Rev. 28, 823-884. doi: 10.1002/med.20125
21. Dingwall, C., and Laskey, R. (1992). The nuclear membrane. Science 258, 942-947. doi: 10.1126/science.1439805
22. Fagerlund, R., Kinnunen, L., Kohler, M., Julkunen, I., and Melen, K. (2005). NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4. J. Biol. Chem. 280, 15942-15951. doi: 10.1074/jbc.M500814200
23. Falsey, A. R., Cunningham, C. K., Barker, W. H., Kouides, R. W., Yuen, J. B., Menegus, M., et al. (1995). Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J. Infect. Dis. 172, 389-394. doi: 10.1093/infdis/172.2.389
24. Feltes, T. F., Sondheimer, H. M., Tulloh, R. M., Harris, B. S., Jensen, K. M., Losonsky, G. A., et al. (2011). A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease. Pediatr. Res. 70, 186-191. doi: 10.1203/PDR.0b013e318220a553
25. Fraser, J. E., Watanabe, S., Wang, C., Chan, W. K., Maher, B., Lopez, A., et al. (2014). A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection. J. Infect. Dis. 210, 1780-1791. doi: 10.1093/infdis/jiu319
26. Fuchs, R., and Blaas, D. (2010). Uncoating of human rhinoviruses. Rev. Med. Virol. 20, 281-297. doi: 10.1002/rmv.654
27. Fulcher, A. J., and Jans, D. A. (2011). Regulation of nucleocytoplasmic trafficking of viral proteins: an integral role in pathogenesis? Biochim. Biophys. Acta 1813, 2176-2190. doi: 10.1016/j.bbamcr.2011.03.019
28. Fulginiti, V. A., Eller, J. J., Sieber, O. F., Joyner, J. W., Minamitani, M., and Meiklejohn, G. (1969). Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89, 435-448.
29. Gao, S., Wang, S., Cao, S., Sun, L., Li, J., Bi, Y., et al. (2014). Characteristics of nucleocytoplasmic transport of H1N1 influenza A virus nuclear export protein. J. Virol. 88, 7455-7463. doi: 10.1128/JVI.00257-14
30. Garcia, J., Sovero, M., Torres, A. L., Gomez, J., Douce, R., Barrantes, M., et al. (2009). Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza Other Respir. Viruses 3, 69-74. doi: 10.1111/j.1750-2659.2009.00072.x
31. Ghildyal, R., Baulch-Brown, C., Mills, J., and Meanger, J. (2003). The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch. Virol. 148, 1419-1429.
32. Ghildyal, R., Ho, A., Dias, M., Soegiyono, L., Bardin, P. G., Tran, K. C., et al. (2009a). The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. J. Virol. 83, 5353-5362. doi: 10.1128/JVI.02374-08
33. Ghildyal, R., Jordan, B., Li, D., Dagher, H., Bardin, P. G., Gern, J. E., et al. (2009b). Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. J. Virol. 83, 7349-7352. doi: 10.1128/JVI.01748-08
34. Ghildyal, R., Ho, A., and Jans, D. A. (2006). Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol. Rev. 30, 692-705. doi: 10.1111/j.1574-6976.2006.00025.x
35. Ghildyal, R., Ho, A., Wagstaff, K. M., Dias, M. M., Barton, C. L., Jans, P., et al. (2005a). Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin beta1 independent of importin alpha. Biochemistry 44, 12887-12895. doi: 10.1021/bi050701e
36. Ghildyal, R., Li, D., Peroulis, I., Shields, B., Bardin, P. G., Teng, M. N., et al. (2005b). Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J. Gen. Virol. 86(Pt 7), 1879-1884. doi: 10.1099/vir.0.80829-0
37. Ghildyal, R., Mills, J., Murray, M., Vardaxis, N., and Meanger, J. (2002). Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J. Gen. Virol. 83(Pt 4), 753-757.
38. Greve, J. M., Davis, G., Meyer, A. M., Forte, C. P., Yost, S. C., Marlor, C. W., et al. (1989). The major human rhinovirus receptor is ICAM-1. Cell 56, 839-847. doi: 10.1016/0092-8674(89)90688-0
39. Grunert, R. R., McGahen, J. W., and Davies, W. L. (1965). The in vivo antiviral activity of 1-adamantanamine (amantadine). Prophylactic, I. and therapeutic activity against influenza viruses. Virology 26, 262-269. doi: 10.1016/0042-6822(65)90273-4
40. Gustin, K. E., and Sarnow, P. (2002). Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 76, 8787-8796. doi: 10.1128/JVI.76.17.8787-8796.2002
41. Hallak, L. K., Collins, P. L., Knudson, W., and Peeples, M. E. (2000a). Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271, 264-275. doi: 10.1006/viro.2000.0293
42. Hallak, L. K., Spillmann, D., Collins, P. L., and Peeples, M. E. (2000b). Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74, 10508-10513. doi: 10.1128/JVI.74.22.10508-10513.2000
43. Hiscott, J. (2007). Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282, 15325-15329. doi: 10.1074/jbc.R700002200
44. Hofer, F., Gruenberger, M., Kowalski, H., Machat, H., Huettinger, M., Kuechler, E., et al. (1994). Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. U.S.A. 91, 1839-1842. doi: 10.1073/pnas.91.5.1839
45. Holguera, J., Villar, E., and Munoz-Barroso, I. (2014). Identification of cellular proteins that interact with Newcastle Disease Virus and human Respiratory Syncytial Virus by a two-dimensional virus overlay protein binding assay (VOPBA). Virus Res. 191C, 138-142. doi: 10.1016/j.virusres.2014.07.031
46. Huet, S., Avilov, S. V., Ferbitz, L., Daigle, N., Cusack, S., and Ellenberg, J. (2010). Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy. J. Virol. 84, 1254-1264. doi: 10.1128/JVI.01533-09
47. Hutchinson, E. C., Orr, O. E., Man Liu, S., Engelhardt, O. G., and Fodor, E. (2011). Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5. J. Gen. Virol. 92(Pt 8), 1859-1869. doi: 10.1099/vir.0.032813-0
48. Hutten, S., and Kehlenbach, R. H. (2007). CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 17, 193-201. doi: 10.1016/j.tcb.2007.02.003
49. Itamura, S. (1997). [Structure and function of influenza virus neuraminidase]. Nihon Rinsho 55, 2570-2574.
50. Itoh, M., Haga, I., Li, Q. H., and Fujisawa, J. (2002). Identification of cellular mRNA targets for RNA-binding protein Sam68. Nucleic Acids Res. 30, 5452-5464. doi: 10.1093/nar/gkf673
51. Jacobs, S. E., Lamson, D. M., St George, K., and Walsh, T. J. (2013). Human rhinoviruses. Clin. Microbiol. Rev. 26, 135-162. doi: 10.1128/CMR.00077-12
52. Jans, D. A., and Hubner, S. (1996). Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol. Rev. 76, 651-685.
53. Johnson, V. A., Calvez, V., Gunthard, H. F., Paredes, R., Pillay, D., Shafer, R., et al. (2011). 2011 update of the drug resistance mutations in HIV-1. Top Antivir. Med. 19, 156-164.
54. Josset, L., Frobert, E., and Rosa-Calatrava, M. (2008). Influenza A replication and host nuclear compartments: many changes and many questions. J. Clin. Virol. 43, 381-390. doi: 10.1016/j.jcv.2008.08.017
55. Kaur, G., Lieu, K. G., and Jans, D. A. (2013). 70-kDa heat shock cognate protein hsc70 mediates calmodulin-dependent nuclear import of the sex-determining factor SRY. J. Biol. Chem. 288, 4148-4157. doi: 10.1074/jbc.M112.436741
56. Kipper, S., Hamad, S., Caly, L., Avrahami, D., Bacharach, E., Jans, D. A., et al. (2015). New host factors important for Respiratory Syncytial Virus replication revealed by a novel microfluidics screen for interactors of Matrix protein. Mol. Cell. Proteomics 14, 532-543. doi: 10.1074/mcp.M114.044107
57. Kotla, S., Peng, T., Bumgarner, R. E., and Gustin, K. E. (2008). Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology 374, 399-410. doi: 10.1016/j.virol.2008.01.022
58. Krilov, L. R. (2002). Safety issues related to the administration of ribavirin. Pediat. Infect. Dis. J. 21, 479-481. doi: 10.1097/00006454-200205000-00037
59. Krilov, L. R. (2011). Respiratory syncytial virus disease: update on treatment and prevention. Exp. Rev. Anti. Infect. Ther. 9, 27-32. doi: 10.1586/eri.10.140
60. Kuritzkes, D. R. (2011). Drug Resistance in HIV-1. Curr. Opin. Virol. 1, 582-589. doi: 10.1016/j.coviro.2011.10.020
61. Kutay, U., Bischoff, F. R., Kostka, S., Kraft, R., and Gorlich, D. (1997). Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell. 90, 1061-1071. doi: 10.1016/S0092-8674(00)80372-4
62. Lacroix, C., George, S., Leyssen, P., Hilgenfeld, R., and Neyts, J. (2015). The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir. Antimicrob. Agents Chemother. doi: 10.1128/AAC.00534-15 [Epub ahead of print].
63. Lapalombella, R., Sun, Q., Williams, K., Tangeman, L., Jha, S., Zhong, Y., et al. (2012). Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia. Blood 120, 4621-4634. doi: 10.1182/blood-2012-05-429506
64. La Via, W. V., Notario, G. F., Yu, X. Q., Sharma, S., Noertersheuser, P. A., and Robbie, G. J. (2013). Three monthly doses of palivizumab are not adequate for 5-month protection: a population pharmacokinetic analysis. Pulm Pharmacol. Ther. 26, 666-671. doi: 10.1016/j.pupt.2013.03.007
65. Law, B. J., Carbonell-Estrany, X., and Simoes, E. A. (2002). An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir. Med. 96(Suppl. B), S1-S7. doi: 10.1053/rmed.2002.1294
66. Leonov, H., Astrahan, P., Krugliak, M., and Arkin, I. T. (2011). How do aminoadamantanes block the influenza M2 channel, and how does resistance develop? J. Am. Chem. Soc. 133, 9903-9911. doi: 10.1021/ja202288m
67. Levine, S., Klaiber-Franco, R., and Paradiso, P. R. (1987). Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68(Pt 9), 2521-2524. doi: 10.1099/0022-1317-68-9-2521
68. Liebig, H. D., Seipelt, J., Vassilieva, E., Gradi, A., and Kuechler, E. (2002). A thermosensitive mutant of HRV2 2A proteinase: evidence for direct cleavage of eIF4GI and eIF4GII. FEBS Lett. 523, 53-57. doi: 10.1016/S0014-5793(02)02933-2
69. Lifland, A. W., Jung, J., Alonas, E., Zurla, C., Crowe, J. E. Jr., and Santangelo, P. J. (2012). Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J. Virol. 86, 8245-8258. doi: 10.1128/JVI.00215-12
70. Liu, Q., Bawa, B., Ma, J., Li, F., Ma, W., and Richt, J. A. (2014). A crucial role of N-terminal domain of influenza A virus M1 protein in interaction with swine importin alpha1 protein. Virus Genes 49, 157-162. doi: 10.1007/s11262-014-1068-6
71. Loregian, A., Marsden, H. S., and Palu, G. (2002). Protein-protein interactions as targets for antiviral chemotherapy. Rev. Med. Virol. 12, 239-262. doi: 10.1002/rmv.356
72. Lundgren, J. D., and Lazarus, J. V. (2012). Dampening the effect of drug resistance in HIV: a leap forward. Lancet Infect. Dis. 12, 91-92. doi: 10.1016/S1473-3099(11)70278-X
73. Matz, J. (2013). Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: results of a phase 2 clinical trial. Eur. Respir. Soc. Annu. Congr. 42(Suppl. 57), 1493.
74. McIntyre, C. L., Knowles, N. J., and Simmonds, P. (2013). Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J. Gen. Virol. 94(Pt 8), 1791-1806. doi: 10.1099/vir.0.053686-0
75. Molinari, N. A., Ortega-Sanchez, I. R., Messonnier, M. L., Thompson, W. W., Wortley, P. M., Weintraub, E., et al. (2007). The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25, 5086-5096. doi: 10.1016/j.vaccine.2007.03.046
76. Narayana, K., D'Souza, U. J., Narayan, P., and Kumar, G. (2005). The antiviral drug ribavirin reversibly affects the reproductive parameters in the male Wistar rat. Folia Morphol. (Warsz) 64, 65-71.
77. Neumann, G., Castrucci, M. R., and Kawaoka, Y. (1997). Nuclear import and export of influenza virus nucleoprotein. J. Virol. 71, 9690-9700.
78. Newlands, E. S., Rustin, G. J., and Brampton, M. H. (1996). Phase I trial of elactocin. Br. J. Cancer 74, 648-649. doi: 10.1038/bjc.1996.415
79. Nicholson, K. G., Kent, J., and Ireland, D. C. (1993). Respiratory viruses and exacerbations of asthma in adults. BMJ 307, 982-986. doi: 10.1136/bmj.307.6910.982
80. Ogra, P. L. (2004). Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr. Respir. Rev. 5(Suppl. A), S119-S126. doi: 10.1016/S1526-0542(04)90023-1
81. O'Neill, R. E., Jaskunas, R., Blobel, G., Palese, P., and Moroianu, J. (1995). Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J. Biol. Chem. 270, 22701-22704. doi: 10.1074/jbc.270.39.22701
82. Organization, W. H. (2009). Pandemic Influenza Vaccine Manufacturing Process and Timeline. Available at: http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090806/en/
83. Park, N., Skern, T., and Gustin, K. E. (2010). Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease. J. Biol. Chem. 285, 28796-28805. doi: 10.1074/jbc.M110.143404
84. Patick, A. K., Brothers, M. A., Maldonado, F., Binford, S., Maldonado, O., Fuhrman, S., et al. (2005). In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 49, 2267-2275. doi: 10.1128/AAC.49.6.2267-2275.2005
85. Pelaez, A., Lyon, G. M., Force, S. D., Ramirez, A. M., Neujahr, D. C., Foster, M., et al. (2009). Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J. Heart. Lung. Transplant. 28, 67-71. doi: 10.1016/j.healun.2008.10.008
86. Perwitasari, O., Johnson, S., Yan, X., Howerth, E., Shacham, S., Landesman, Y., et al. (2014). Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. J. Virol. 88, 10228-10243. doi: 10.1128/JVI.01774-14
87. Prasetyo, A. A., Kamahora, T., Kuroishi, A., Murakami, K., and Hino, S. (2009). Replication of chicken anemia virus (CAV) requires apoptin and is complemented by VP3 of human torque teno virus (TTV). Virology 385, 85-92. doi: 10.1016/j.virol.2008.10.043
88. Pumroy, R. A., Ke, S., Hart, D. J., Zachariae, U., and Cingolani, G. (2015). Molecular determinants for nuclear import of influenza A PB2 by importin alpha isoforms 3 and 7. Structure 23, 374-384. doi: 10.1016/j.str.2014.11.015
89. Ramilo, O., Lagos, R., Saez-Llorens, X., Suzich, J., Wang, C. K., Jensen, K. M., et al. (2014). Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness. Pediatr. Infect. Dis. J. 33, 703-709. doi: 10.1097/INF.0000000000000240
90. Rawlinson, S. M., Pryor, M. J., Wright, P. J., and Jans, D. A. (2009). CRM1-mediated nuclear export of dengue virus RNA polymerase NS5 modulates interleukin-8 induction and virus production. J. Biol. Chem. 284, 15589-15597. doi: 10.1074/jbc.M808271200
91. Read, E. K., and Digard, P. (2010). Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export. J. Gen. Virol. 91(Pt 5), 1290-1301. doi: 10.1099/vir.0.018564-0
92. Reichelt, R., Holzenburg, A., Buhle, E. L. Jr., Jarnik, M., Engel, A., and Aebi, U. (1990). Correlation between structure and mass distribution of the nuclear pore complex and of distinct pore complex components. J. Cell Biol. 110, 883-894. doi: 10.1083/jcb.110.4.883
93. Resa-Infante, P., Jorba, N., Zamarreno, N., Fernandez, Y., Juarez, S., and Ortin, J. (2008). The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication. PLoS ONE 3:e3904. doi: 10.1371/journal.pone.0003904
94. Rout, M. P., Aitchison, J. D., Suprapto, A., Hjertaas, K., Zhao, Y., and Chait, B. T. (2000). The yeast nuclear pore complex: composition, architecture, and transport mechanism. J. Cell Biol. 148, 635-651. doi: 10.1083/jcb.148.4.635
95. Saez-Llorens, X., Castano, E., Null, D., Steichen, J., Sanchez, P. J., Ramilo, O., et al. (1998). Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group. Pediatr. Infect. Dis. J. 17, 787-791. doi: 10.1097/00006454-199809000-00007
96. Samji, T. (2009). Influenza A: understanding the viral life cycle. Yale J. Biol. Med. 82, 153-159.
97. Shtyrya, Y. A., Mochalova, L. V., and Bovin, N. V. (2009). Influenza virus neuraminidase: structure and function. Acta Nat. 1, 26-32.
98. Simoes, E. A. (2008). RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes. Manag. Care 17(11 Suppl. 12), 3-6.
99. Skar, H., Hedskog, C., and Albert, J. (2011). HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance. Ann. N. Y. Acad. Sci. 1230, 108-118. doi: 10.1111/j.1749-6632.2011.06128.x
100. Skern, T., Sommergruber, W., Blaas, D., Gruendler, P., Fraundorfer, F., Pieler, C., et al. (1985). Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Res. 13, 2111-2126. doi: 10.1093/nar/13.6.2111
101. Stewart, M. (2007). Molecular mechanism of the nuclear protein import cycle. Nat. Rev. Mol. Cell Biol. 8, 195-208. doi: 10.1038/nrm2114
102. Talcott, B., and Moore, M. S. (1999). Getting across the nuclear pore complex. Trends Cell Biol. 9, 312-318. doi: 10.1016/S0962-8924(99)01608-6
103. Tapparel, C., Junier, T., Gerlach, D., Cordey, S., Van Belle, S., Perrin, L., et al. (2007). New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features. BMC Genomics 8:224. doi: 10.1186/1471-2164-8-224
104. Tayyari, F., Marchant, D., Moraes, T. J., Duan, W., Mastrangelo, P., and Hegele, R. G. (2011). Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17, 1132-1135. doi: 10.1038/nm.2444
105. Thibaut, H. J., De Palma, A. M., and Neyts, J. (2012). Combating enterovirus replication: state-of-the-art on antiviral research. Biochem. Pharmacol. 83, 185-192. doi: 10.1016/j.bcp.2011.08.016
106. Thompson, A. J., and Locarnini, S. A. (2007). Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell Biol. 85, 435-445. doi: 10.1038/sj.icb.7100100
107. Torgerson, T. R., Colosia, A. D., Donahue, J. P., Lin, Y. Z., and Hawiger, J. (1998). Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J. Immunol. 161, 6084-6092.
108. Tran, D. N., Pham, T. M., Ha, M. T., Tran, T. T., Dang, T. K., Yoshida, L. M., et al. (2013). Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS ONE 8:e45436. doi: 10.1371/journal.pone.0045436
109. Tyrrell, D. A., Bynoe, M. L., and Hoorn, B. (1965). Studies on the antiviral activity of 1-adamantanamine. Br. J. Exp. Pathol. 46, 370-375.
110. Ugrinova, I., Monier, K., Ivaldi, C., Thiry, M., Storck, S., Mongelard, F., et al. (2007). Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol. Biol. 8:66. doi: 10.1186/1471-2199-8-66
111. Ventre, K., and Randolph, A. G. (2007). Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst. Rev. 2007:CD000181. doi: 10.1002/14651858.CD000181.pub3
112. Wagstaff, K. M., Rawlinson, S. M., Hearps, A. C., and Jans, D. A. (2011). An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import. J. Biomol. Screen. 16, 192-200. doi: 10.1177/1087057110390360
113. Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., and Jans, D. A. (2012). Ivermectin is a specific inhibitor of importin alpha/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem. J. 443, 851-856. doi: 10.1042/BJ20120150
114. Walker, E. J., Younessi, P., Fulcher, A. J., McCuaig, R., Thomas, B. J., Bardin, P. G., et al. (2013). Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells. PLoS ONE 8:e71316. doi: 10.1371/journal.pone.0071316
115. Watanabe, K., Shimizu, T., Noda, S., Tsukahara, F., Maru, Y., and Kobayashi, N. (2014). Nuclear export of the influenza virus ribonucleoprotein complex: Interaction of Hsc70 with viral proteins M1 and NS2. FEBS Open. Biol. 4, 683-688. doi: 10.1016/j.fob.2014.07.004
116. Watanabe, K., Takizawa, N., Noda, S., Tsukahara, F., Maru, Y., and Kobayashi, N. (2008). Hsc70 regulates the nuclear export but not the import of influenza viral RNP: A possible target for the development of anti-influenza virus drugs. Drug Discov. Ther. 2, 77-84.
117. Watters, K., and Palmenberg, A. C. (2011). Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes. J. Virol. 85, 10874-10883. doi: 10.1128/JVI.00718-11
118. Whittaker, G., Bui, M., and Helenius, A. (1996). The role of nuclear import and export in influenza virus infection. Trends Cell Biol. 6, 67-71. doi: 10.1016/0962-8924(96)81017-8
119. WHO. (2009). Acute Respiratory Infections. Available at: http://www.who.int/vaccine_research/diseases/ari/en/index2.html [accessed 26 October, 2012].
120. Wolin, S. L., and Cedervall, T. (2002). The La protein. Annu. Rev. Biochem. 71, 375-403. doi: 10.1146/annurev.biochem.71.090501.150003
121. Wu, W. W., Sun, Y. H., and Pante, N. (2007). Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol. J. 4, 49. doi: 10.1186/1743-422X-4-49
122. Yang, S. N., Takeda, A. A., Fontes, M. R., Harris, J. M., Jans, D. A., and Kobe, B. (2010). Probing the specificity of binding to the major nuclear localization sequence-binding site of importin-alpha using oriented peptide library screening. J. Biol. Chem. 285, 19935-19946. doi: 10.1074/jbc.M109.079574
123. Yano, T., Nobusawa, E., Nagy, A., Nakajima, S., and Nakajima, K. (2008). Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus. Microbiol. Immunol. 52, 216-223. doi: 10.1111/j.1348-0421.2008.00034.x
124. Yen, H. L., Hoffmann, E., Taylor, G., Scholtissek, C., Monto, A. S., Webster, R. G., et al. (2006). Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses. J. Virol. 80, 8787-8795. doi: 10.1128/JVI.00477-06
125. Zhong, C., Li, C., Wang, X., Toyoda, T., Gao, G., and Fan, Z. (2012). Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin alpha1/beta dimer of infected host cells. Cell Death. Diff. 19, 882-890. doi: 10.1038/cdd.2011.178